The pathology of hypertrophic cardiomyopathy (Q35771667)

10 August 2017

1 reference

title

The pathology of hypertrophic cardiomyopathy (English)

1 reference

10 August 2017

Hughes SE

1 reference

10 August 2017

publication date

1 May 2004

1 reference

10 August 2017

1 reference

10 August 2017

1 reference

10 August 2017

1 reference

10 August 2017

page(s)

412-427

1 reference

Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Clinical course of hypertrophic cardiomyopathy in a regional United States cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Prognosis in hypertrophic cardiomyopathy observed in a large clinic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Natural history of hypertrophic cardiomyopathy. A population-based study, 1976 through 1990.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Hypertrophic cardiomyopathy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Prognosis of completely asymptomatic adult patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Cardiomyopathy: The diagnosis of hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Significance in producing left ventricular outflow obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Pitfalls in clinical recognition and a novel operative approach for hypertrophic cardiomyopathy with severe outflow obstruction due to anomalous papillary muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Clinical and morphologic features of hypertrophic cardiomyopathy in elderly patients 85 years or older

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Mid-ventricular obstruction: a variant of obstructive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

A novel mutation Lys273Glu in the cardiac troponin T gene shows high degree of penetrance and transition from hypertrophic to dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum. Comparison of fetuses and infants with and without congenital heart disease and patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Asymmetric septal hypertrophy and myocardial fiber disarray. Features of normal, developing, and malformed hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Muscle fiber disarray in common heart diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

The molecular genetic basis for hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Functional analysis of a troponin I (R145G) mutation associated with familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Familial hypertrophic cardiomyopathy: from mutations to functional defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

First description of germline mosaicism in familial hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Identification of a gene responsible for familial Wolff-Parkinson-White syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Sudden death due to troponin T mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

On genetic and phenotypic variability of hypertrophic cardiomyopathy: nature versus nurture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Clinical Features of Hypertrophic Cardiomyopathy Caused by Mutation of a “Hot Spot” in the Alpha-Tropomyosin Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Contractile protein mutations and heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Manipulating the contractile apparatus: genetically defined animal models of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Dynamic left ventricular outflow tract obstruction in cardiac amyloidosis detected by continuous-wave Doppler echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Fabry disease in patients with hypertrophic cardiomyopathy (HCM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Fabry disease: a mimic for obstructive hypertrophic cardiomyopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Predictors of sudden cardiac death in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Role of DNA testing for diagnosis, management, and genetic screening in long QT syndrome, hypertrophic cardiomyopathy, and Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Hypertrophic cardiomyopathy: from bedside to bench...and now back again?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Epidemiology of Hypertrophic Cardiomyopathy–Related Death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

New insights in cardiac structural changes in patients with Fabry’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01835.X

10.1111/J.1365-2559.2004.01835.X

21 January 2018

Identifiers

DOI

1 reference

release_jlp6duaycjhibdmwbqtu4mtinq

10 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jlp6duaycjhibdmwbqtu4mtinq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference